Charles J Yeo

5PUBLICATIONS
11CO-AUTHORS
Tumour immunologyPredictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 15, 2026
Neoadjuvant Immunotherapy for Hepatocellular Carcinoma Is Associated with Improved Survival After Hepatectomy: A Matched Analysis of the 2017 to 2022 National Cancer Database.

|Apr 17, 2025
Gene Expression Profiling of Pancreatic Ductal Adenocarcinoma Cells in Hypercapnia Identifies SIAH3 as a Novel Prognostic Biomarker.

Nitzan Zohar, Ryan Maguire, Saed Khalilieh

|Feb 26, 2025
Correlation of GNAS Mutational Status with Oncologic Outcomes in Patients with Resected Intraductal Papillary Mucinous Neoplasms.

Julia Evans, Kylee Shivok, Hui Hsuan Chen

|Oct 26, 2024
Assessing Influence of Mismatch Repair Mutations on Survival in Patients After Resection of Pancreatic Ductal and Periampullary Adenocarcinoma.

Elizabeth Prezioso, Eleanor Mancheski, Kylee Shivok

|Jan 21, 2017
Thymoquinone Promotes Pancreatic Cancer Cell Death and Reduction of Tumor Size through Combined Inhibition of Histone Deacetylation and Induction of Histone Acetylation.

Daniel Relles, Galina I Chipitsyna, Qiaoke Gong

Pageof 1

Frequent Collaborators

3 joint publications

Aditi Jain

3 joint publications

Avinoam Nevler

1 joint publications

Galina I Chipitsyna

1 joint publications

Hwyda A Arafat